Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote & News

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 665 9295

Website: www.boltbio.com

Address:

900 Chesapeake Drive, Redwood City, United States

rp6577 Aug. 22 at 4:52 PM

$BOLT a bit of news, perhaps the partnership they have been working on, and this roars

0 · Reply

goandgo Aug. 22 at 6:36 AM

$BOLT why downtrend? dilution or clinical trials failure? should I sell all shares before it gets lower?

0 · Reply

StockTwitsGhost Aug. 21 at 2:44 PM

$BOLT One of the easiest short calls. Everyday 5%. Like having a personally owned ATM.

0 · Reply

SDBiotechInvestor Aug. 20 at 5:14 PM

$CYCN - With the market topping this week and tech plummeting ,$CYCN is a great place to park your money for TRD inlicense news. No downside, whereas you see $BOLT and $PEPG bleed daily. If my theory of beacon biosignals is correct, when the announcement comes sky is the limit.

0 · Reply

AshleySchaeffer_BMW Aug. 20 at 4:49 PM

$BOLT will cover at 2 like my buddy Ghost dog been saying, all that profit full porting into $CYCN all for bioturd valoooes

2 · Reply

StockTwitsGhost Aug. 19 at 9:29 PM

$BOLT was an easy short when the call was made on Aug 06. Sub $2 is the ideal cover zone. ✌🏿🕊️

0 · Reply

skyrockets_Inc Aug. 18 at 6:02 PM

$BOLT I'm a buyer sub $4 before after they announce trial failure/halting and announce strategic alternatives. GBIO just did it, NERV just did it, and BOLT will do it before EOY

0 · Reply

AshleySchaeffer_BMW Aug. 18 at 4:00 PM

$BOLT where's bioturd values?

0 · Reply

builderup Aug. 18 at 1:44 AM

Weekly Watchlist $BOLT $ZVIA $MVST

0 · Reply

Bullbear1010101 Aug. 17 at 11:11 PM

$BOLT quite the trend down

0 · Reply

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:05 PM EDT - 3 months ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 8:00 AM EDT - 3 months ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Apr 30, 2025, 4:05 PM EDT - 4 months ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Apr 25, 2025, 1:00 PM EDT - 4 months ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 5 months ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 24, 2025, 4:20 PM EDT - 5 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Feb 25, 2025, 4:05 PM EST - 6 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Feb 11, 2025, 4:05 PM EST - 6 months ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Nov 7, 2024, 10:00 AM EST - 10 months ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Sep 6, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 2, 2024, 11:11 AM EDT - 1 year ago

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

$Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions$

Sep 2, 2024, 11:00 AM EDT - 1 year ago

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

Aug 31, 2024, 11:25 AM EDT - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

$Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm$

Aug 31, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

Aug 29, 2024, 8:49 PM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

$A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm$

Aug 27, 2024, 11:00 AM EDT - 1 year ago

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 26, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

Jul 25, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Jul 19, 2024, 11:10 AM EDT - 1 year ago

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Jul 3, 2024, 4:47 PM EDT - 1 year ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Jun 24, 2024, 3:36 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

May 17, 2024, 8:37 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

rp6577 Aug. 22 at 4:52 PM

$BOLT a bit of news, perhaps the partnership they have been working on, and this roars

0 · Reply

goandgo Aug. 22 at 6:36 AM

$BOLT why downtrend? dilution or clinical trials failure? should I sell all shares before it gets lower?

0 · Reply

StockTwitsGhost Aug. 21 at 2:44 PM

$BOLT One of the easiest short calls. Everyday 5%. Like having a personally owned ATM.

0 · Reply

SDBiotechInvestor Aug. 20 at 5:14 PM

0 · Reply

AshleySchaeffer_BMW Aug. 20 at 4:49 PM

$BOLT will cover at 2 like my buddy Ghost dog been saying, all that profit full porting into $CYCN all for bioturd valoooes

2 · Reply

StockTwitsGhost Aug. 19 at 9:29 PM

$BOLT was an easy short when the call was made on Aug 06. Sub $2 is the ideal cover zone. ✌🏿🕊️

0 · Reply

skyrockets_Inc Aug. 18 at 6:02 PM

$BOLT I'm a buyer sub $4 before after they announce trial failure/halting and announce strategic alternatives. GBIO just did it, NERV just did it, and BOLT will do it before EOY

0 · Reply

AshleySchaeffer_BMW Aug. 18 at 4:00 PM

$BOLT where's bioturd values?

0 · Reply

builderup Aug. 18 at 1:44 AM

Weekly Watchlist $BOLT $ZVIA $MVST

0 · Reply

Bullbear1010101 Aug. 17 at 11:11 PM

$BOLT quite the trend down

0 · Reply

d_risk Aug. 16 at 11:09 PM

$BOLT - Bolt Biotherapeutics, Inc. - 10Q - Updated Risk Factors BOLT flags new risks from global trade tensions, tariffs, and healthcare reform, warning of potential supply chain delays, higher costs, regulatory hurdles, and threats to international growth and product commercialization. #Biotechnology #RegulatoryChallenges #SupplyChainRisk #GlobalTradeTensions #HealthcareReform 🟢 Added 🟠 Removed https://d-risk.ai/BOLT/10-Q/2025-08-14

0 · Reply

AshleySchaeffer_BMW Aug. 16 at 6:38 PM

$BOLT printed 52 week low yesterday, new lows coming in the days and weeks ahead, pressing shall now commence

0 · Reply

SDBiotechInvestor Aug. 15 at 6:16 PM

$CYCN Oh boy. BV already deleted his $BOLT posts. When $CYCN has news (thanks Dina), he will delete all his CYCN's too.

2 · Reply

SDBiotechInvestor Aug. 15 at 2:51 AM

$BOLT - You can't run from the truth -

0 · Reply

SDBiotechInvestor Aug. 15 at 2:49 AM

$BOLT - BV dumped 35k shares ahead of today. After weeks of pumping calling this the next great thing. My guess it's sub $5 tomorrow. LMAO the ER was a joke.

0 · Reply

AshleySchaeffer_BMW Aug. 15 at 2:24 AM

$BOLT lol

1 · Reply

BiotechValues Aug. 14 at 9:24 PM

$BOLT biggest takeaway from 10q is they are reiterating that they are still in a formal partnering process for the DECTIN-2 agonist. Back in May they said term sheets were due in early June and they expected a deal by fall (which is only 45 days out)

1 · Reply

BiotechValues Aug. 14 at 8:11 PM

$BOLT reiterating they are working to partner BDC-4082 (good sign, as preliminary term sheets were due in June and they would have not mentioned partnering anymore if it was off the table). $10M market cap vs. $48M cash. Last guidance was a "deal by the fall." Major data coming soon in 1H 2026

1 · Reply

skyrockets_Inc Aug. 14 at 8:11 PM

$BOLT lots of cash burn on this one. They definitely need a partner asap

2 · Reply

SDBiotechInvestor Aug. 14 at 8:07 PM

$BOLT No data until 1H 2026. Typical $BCAB response about partner. Dead money.

2 · Reply

SDBiotechInvestor Aug. 14 at 5:16 PM

$CYCN $BOLT. I'll be you $CYCN goes 5x before $BOLT even moves ;)

1 · Reply

SDBiotechInvestor Aug. 14 at 4:00 PM

$CYCN - The only fraud is BV. He has owned CYCN 3 times in past month only to dump. He also pumped his scam $BOLT only to dump a few weeks later.

0 · Reply

Market Cap	9.89M
Revenue (ttm)	7.69M
Net Income (ttm)	-63.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-820.81%
Debt to Equity Ratio	0.00

Volume	13,203
Avg Vol	19,398
Day's Range	N/A - N/A
Shares Out	1.92M
Stochastic %K	40%
Beta	0.90
Analysts	Hold
Price Target	$20.00